FDAMA Pediatric Incentives Should Apply To Biologics, PhRMA Testifies

FDA may be willing to discuss new incentives for manufacturers to conduct pediatric studies on products not covered under the FDA Modernization Act's pediatric exclusivity rule, FDA Commissioner Henney said Oct. 21 at a hearing of the Senate Health, Education, Labor & Pensions Committee.